Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-26 @ 2:46 AM
Study NCT ID:
NCT04438902
Status:
TERMINATED
Last Update Posted:
2023-02-21
First Post:
2020-06-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Osimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib Treatment
Sponsor:
First Affiliated Hospital of Zhejiang University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-16
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-15
First Submit QC Date:
None
Study First Post Date:
2020-06-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-17
Last Update Post Date:
2023-02-21
Last Update Post Date Type:
ACTUAL